Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Cardiovascular Events”

351 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 351 results

Not applicableLooking for participantsNCT06586424
What this trial is testing

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

Who this might be right for
ST-segment Elevation Myocardial Infarction (STEMI)
Universitas Diponegoro 80
Not applicableStudy completedNCT06007274
What this trial is testing

Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune Checkpoint InhibitorCardiovascular Biomarkers
Institut Mutualiste Montsouris 300
Post-approval studies (Phase 4)Looking for participantsNCT06725810
What this trial is testing

Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Associated Anemia
Shanghai Zhongshan Hospital 1,670
Not applicableLooking for participantsNCT04691037
What this trial is testing

CCTA Improves Clinical Management of Stable Chest Pain

Who this might be right for
Coronary Computed Tomography AngiographyStable Chest PainOptimal Medical Therapy+4 more
Tianjin Chest Hospital 50,000
Not applicableLooking for participantsNCT05778981
What this trial is testing

Endothelial Dysfunction and Non-cardiac Surgery

Who this might be right for
SurgeryCardiac DeathStroke+1 more
University of Chile 200
Not applicableStudy completedNCT05438472
What this trial is testing

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

Who this might be right for
Myocarditis
University Hospital, Basel, Switzerland 835
Not applicableStudy completedNCT02097602
What this trial is testing

Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery

Who this might be right for
Cardiac DeathCongestive Heart FailureAngina Pectoris+3 more
Technical University of Munich 1,000
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Large-scale testing (Phase 3)Active Not RecruitingNCT01878669
What this trial is testing

Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

Who this might be right for
Coronary Artery Disease
Suleyman Demirel University 390
Not applicableStudy completedNCT01262222
What this trial is testing

Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events

Who this might be right for
High Risk for Postoperative Cardiovascular Events
Memorial Sloan Kettering Cancer Center 67
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Not applicableActive Not RecruitingNCT06855394
What this trial is testing

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

Who this might be right for
Atherosclerotic Vascular DiseaseCoronary Arterial Disease (CAD)Atherosclerosis of Coronary Artery+4 more
University of Florida 13,000
Not applicableStudy completedNCT02317445
What this trial is testing

Relationship of Helicobacter Pylori Eradication Therapy and Long-term Outcome in Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Capital Medical University 472
Not applicableStudy completedNCT03606330
What this trial is testing

Systemic, Pancoronary and Local Coronary Vulnerability

Who this might be right for
Coronary StenosisAcute Coronary SyndromeAcute Myocardial Infarction+3 more
Cardio Med Medical Center 100
Testing effectiveness (Phase 2)UnknownNCT01761656
What this trial is testing

Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR

Who this might be right for
Stable AnginaUnstable AnginaAcute Non-ST-segment Elevation Myocardial Infarction
Central South University 180
Post-approval studies (Phase 4)UnknownNCT03620760
What this trial is testing

Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Who this might be right for
Unstable Angina PectorisCoronary Stent Implantation
Xiaofan Wu 2,036
Not applicableStudy completedNCT04430920
What this trial is testing

Blood Pressure Management on Cardiovascular AdveRse Events After Major Abdominal Surgery

Who this might be right for
Cardiovascular Complication
Nanfang Hospital, Southern Medical University 1,500
Not applicableUnknownNCT04087915
What this trial is testing

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD)

Who this might be right for
DyslipidemiaHigh Risk Coronary Artery Disease
Beijing Anzhen Hospital 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04023552
What this trial is testing

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 8,323
Load More Results